Early Detection Research Network


This biomarker is also known as:
  • LIM domain only 5, smooth muscle,
  • SMLIM,
  • CRP2,
  • cysteine and glycine-rich protein 2,
  • LMO5,
  • cysteine-rich protein 2,
  • LIM domain only protein 5,
  • Cysteine-rich protein 2,
  • smooth muscle cell LIM protein,
  • CSRP2,
  • LMO-5,
  • SmLIM,
  • Smooth muscle cell LIM protein,


CSRP2 encodes a LIM domain protein. LIM domain proteins may be involved in regulatory processes important for development and cellular differentiation. CSRP2 has two copies of the cysteine-rich amino acid sequence motif (LIM) with putative zinc-binding activity, and may be involved in regulating ordered cell growth. CSRP2 is thought to play a role in the development of the embryonic vascular system.


There are no datasets associated with this biomarker.

QA State: Curated
Type: Protein

The following organs have data associated with this biomarker…


Phase: Two
QA State: Under Review


No additional breast data available.

Performance Comment

CSRP2 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

No associated publications found.